Cross-frequency coupling between gamma oscillations and deep brain stimulation frequency in Parkinson's disease. by Muthuraman, Muthuraman et al.
Cross-frequency coupling between gamma
oscillations and deep brain stimulation
frequency in Parkinson’s disease
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The disruption of pathologically enhanced beta oscillations is considered one of the key mechanisms mediating the clinical effects
of deep brain stimulation on motor symptoms in Parkinson’s disease. However, a specific modulation of other distinct physiologic-
al or pathological oscillatory activities could also play an important role in symptom control and motor function recovery during
deep brain stimulation. Finely tuned gamma oscillations have been suggested to be prokinetic in nature, facilitating the preferential
processing of physiological neural activity. In this study, we postulate that clinically effective high-frequency stimulation of the sub-
thalamic nucleus imposes cross-frequency interactions with gamma oscillations in a cortico-subcortical network of interconnected
regions and normalizes the balance between beta and gamma oscillations. To this end we acquired resting state high-density (256
channels) EEG from 31 patients with Parkinson’s disease who underwent deep brain stimulation to compare spectral power and
power-to-power cross-frequency coupling using a beamformer algorithm for coherent sources. To show that modulations exclu-
sively relate to stimulation frequencies that alleviate motor symptoms, two clinically ineffective frequencies were tested as control
conditions. We observed a robust reduction of beta and increase of gamma power, attested in the regions of a cortical (motor cor-
tex, supplementary motor area, premotor cortex) and subcortical network (subthalamic nucleus and cerebellum). Additionally, we
found a clear cross-frequency coupling of narrowband gamma frequencies to the stimulation frequency in all of these nodes, which
negatively correlated with motor impairment. No such dynamics were revealed within the control posterior parietal cortex region.
Furthermore, deep brain stimulation at clinically ineffective frequencies did not alter the source power spectra or cross-frequency
coupling in any region. These findings demonstrate that clinically effective deep brain stimulation of the subthalamic nucleus
differentially modifies different oscillatory activities in a widespread network of cortical and subcortical regions. Particularly the
cross-frequency interactions between finely tuned gamma oscillations and the stimulation frequency may suggest an entrainment
mechanism that could promote dynamic neural processing underlying motor symptom alleviation.
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Introduction
Deep brain stimulation (DBS) is a well-established treatment
for alleviating motor symptoms in Parkinson’s disease
(Deuschl et al., 2006; Allert et al., 2018). Parkinson’s disease
affects the function of cortico-basal ganglia brain networks
and it has been hypothesized that DBS not only acts locally
in the targeted nucleus, but that the disruption of pathologic-
al signals passing through the latter might allow physiologic-
al activity to reappear within the network’s subregions
(Helmich et al., 2013; Chiken and Nambu, 2016;
Muthuraman et al., 2018a).
For example, beta band oscillations, as observed in EEG,
magnetoencephalography (MEG), and local field potential
(LFP) recordings are increased in Parkinson’s disease
patients, which might constrain neural activity into an in-
flexible pattern that limits information coding capacity and
prevents dynamic processing within the cortico-basal ganglia
network (Brown et al., 2001; Litvak et al., 2012; Brittain
and Brown, 2014; de Hemptinne et al., 2015; Swann et al.,
2016; Tinkhauser et al., 2017). Dopaminergic medication as
well as DBS modifies beta oscillations within the basal gan-
glia and cortex; the extent of the observed alterations corre-
lates with clinical improvement (Kühn et al., 2006;
Neumann et al., 2016; Oswal et al., 2016; Tinkhauser et al.,
2018) as well as the performance of a pronation-supination
motor task (Kühn et al., 2008). Recently it was suggested
that adaptive DBS can improve clinical efficiency by select-
ively targeting prolonged beta bursts instead of reducing
overall beta power (Tinkhauser et al., 2017).
Similarly, gamma oscillations (i.e. oscillations of frequen-
cies 430 Hz) in the basal ganglia and cortex are modulated
by DBS and dopaminergic treatment. Contrary to the antiki-
netic effect of beta oscillations, gamma activity supposedly
acts in a prokinetic fashion (Brown, 2003; Litvak et al.,
2012). In the subthalamic nucleus (STN), finely tuned
gamma (FTG) activity between 60 and 90 Hz is increased
following dopaminergic treatment (Alonso-Frech et al.,
2006; Androulidakis et al., 2007) and the extent of amplifi-
cation correlates negatively with motor impairment (Lofredi
et al., 2018). Litvak et al. (2012) showed that dopaminergic
treatment increases movement-related gamma reactivity
within the motor cortex (M1) and STN and that the extent
of reactivity within the STN as well as the coherence be-
tween STN and M1 correlate with motor improvement.
Gamma information flow between cortical motor regions
and the STN is also increased by dopaminergic treatment
(Lalo et al., 2008). However, a recent study demonstrated
that STN-DBS increases gamma activity over frontal and
parietal areas in Parkinson’s disease patients, which corre-
lates negatively with symptom alleviation (Cao et al., 2017).
Exaggerated cortical narrowband gamma was associated
with dyskinesia and could serve as a control signal for adap-
tive DBS (Swann et al., 2016, 2018).
Given the proposed antagonistic functions of beta and
gamma activities we raise the question whether a reciprocal
linear relationship between the two frequency bands exists.
Furthermore, while it was shown that adaptive DBS can act
to truncate exaggerated beta bursts (Tinkhauser et al.,
2017), we investigate whether modifications of gamma band
activity are secondary to reduced beta activity (i.e. if reduc-
tions of beta activity allow gamma oscillations to reappear
in the network) or directly relate to the stimulation itself,
possibly due to an immediate entrainment (Buzsaki and
Wang, 2012).
Recently, it has been proposed to study Parkinson’s dis-
ease on a systems or network-level, considering the anatom-
ical and functional interactions of the basal ganglia with the
cortex, cerebellum (CER), and brainstem (Helmich et al.,
2013; Caligiore et al., 2016). Since effective DBS simultan-
eously affects multiple regions that are connected with the
stimulation site (Koirala et al., 2016, 2018; Muthuraman
et al., 2017), our understanding is that we must study the
effects of DBS on a wide network instead of (pre-) selected
regions. Recent advances in EEG source reconstruction have
made it possible to non-invasively reveal cortical and subcor-
tical sources with an improved spatial resolution, adding to
the advantage of having a good temporal resolution (Litvak
et al., 2011; Muthuraman et al., 2012, 2018b; Tamas et al.,
2018; Seeber et al., 2019). We used high-density (HD)-EEG
with 256 channels to investigate DBS-dependent modula-
tions of beta and gamma oscillations during rest. The rele-
vant regions were defined with a coherent source
beamforming algorithm (Muthuraman et al., 2018b) that
used the volume of tissue activated (VTA) by DBS (Horn
and Kühn, 2015) as a seed region. We hypothesized that
clinically effective high frequency DBS of the STN modifies
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beta and gamma oscillations in a wide cortico-subcortical
network of connected regions and investigated whether these
two bands are related by performing correlation analyses be-
tween beta- and gamma band power. To investigate whether
such dynamics are coupled to the occurrence of stimulation
we further calculated the cross-frequency coupling (CFC) be-
tween the stimulation frequency and beta- or gamma-band
frequencies.
Materials and methods
Patient demographics and data
acquisition
Thirty-one patients with clinically definite Parkinson’s disease,
as diagnosed by the London Brain Bank criteria (Hughes et al.,
1992), participated in our study. All patients were chronically
treated with DBS for 6–12 months prior to study participation.
Over this period, subjects were maintained at stimulation fre-
quencies that were individually optimized and then fixed, irre-
spective of their future potential participation in the study.
Sixteen patients achieved optimal improvement of motor symp-
toms with 160 Hz DBS. The other 15 patients received 130 Hz
stimulation for optimal benefit. Clinical parameters were
obtained by experienced clinicians who were blinded to the
applied DBS frequency. Patient demographics are shown in
Table 1. We recorded 10 min of resting state EEG activity for
four different conditions: (i) stimulation switched off (Off); (ii)
stimulation at clinically effective frequency (On-clinical; could
be 130 Hz or 160 Hz); (iii) stimulation 20 Hz below the clinic-
ally effective stimulation (On-low); and (iv) stimulation 20 Hz
above the clinically effective stimulation (On-high). Stimulation
was delivered in a monopolar fashion. The field isolation con-
tainment system with front-end filters that usually compensate
for high frequency magnetic resonance gradient artefacts pre-
vented the amplifier of the MRI compatible EEG system from
saturating. The order of the four conditions was pseudorandom-
ized and we allowed for 45 min of washout period after switch-
ing the stimulation off. All participants were seated in a
comfortable chair in a slightly reclined position, with both fore-
arms supported to the wrists by firm armrests. Dopaminergic
medications were withdrawn at least 12 h before the study.
EEG was recorded with a high density 256-channel recording
system [Electrical Geodesics, Inc. (EGI), Philips], with Cz as ref-
erence at a sampling rate of 5000 Hz. Data were analysed off-
line. All patients underwent preoperative MRI using a 3 T MRI
scanner (Siemens TrioTim) with a 32-channel head coil and
postoperative CT scan using a Toshiba Aquilian with slice thick-
ness of 0.5 mm. This included whole-brain high resolution T1-
images using standard MPRAGE (magnetization-prepared 180
radio-frequency pulses and rapid gradient-echo) sequence with
repetition time = 1900 ms, echo time = 2.52 ms, flip angle = 9
and voxel resolution of 11  1 mm3. The study protocol was
approved by the local ethics committee in Mainz and all
patients provided written informed consent before the
procedure.
Preprocessing and time frequency
analyses
EEG data preprocessing and part of the spatial filter analyses
were performed using MATLAB (version 2015a, Mathworks
Inc.) and the fieldtrip toolbox (Oostenveld et al., 2011). The ini-
tial preprocessing steps were performed by a researcher who
was blinded to the stimulation conditions. Initially, EEG data
were re-referenced to the common grand average reference of all
channels. The raw data were low-pass filtered (fourth-order
Butterworth filter; cut-off frequency: 500 Hz) to avoid aliasing,
followed by high-pass filtering at 0.5 Hz. Then, data were sub-
jected to independent component analyses (FastICA) to remove
components related to DBS, muscle, eye blink, eye movement
and line noise artefacts. On average, 16 of 256 components
[16±2.3, mean ± standard deviation (SD) were rejected (DBS
artefact: 6±1.24; eye artefact: 5±0.68; line noise: 2±0.34;
muscle artefacts: 2±1.21]. Residual muscle artefacts were visu-
ally inspected, removed and interpolated with the cubic interpol-
ation method. Continuous data were then decomposed into
their time-frequency representation using the multitaper method
(Mitra and Pesaran, 1999; Muthuraman et al., 2010a). Seven
orthogonal tapers were used with good leakage and spectral
properties, and discrete prolate spheroidal sequences (DPSS)
were applied (Pollak and Slepian, 1961).
Reconstruction of brain activity
To solve the EEG forward problem in source reconstruction, we
estimated a volume conduction model and the lead-field matrix
(LFM) containing information about the geometry and conduct-
ivity with the finite-element method (FEM) (Wolters et al.,
2007). Skin, skull, CSF, and grey and white matter surfaces
were extracted from the individual anatomical T1-MPRAGE
scans and individual electrode locations were used. A complete
description has been described previously (Muthuraman et al.,
2010b, 2012). A full description of the beamformer linear con-
strained minimum variance spatial filter is given elsewhere (Van
Veen et al., 1997; Muthuraman et al., 2018b). The output of
the beamformer at a voxel in the brain can be defined as a
weighted sum of the output of all EEG channels. The frequency
Table 1 Demographics and clinical details of study
participants
Parameters Stimulation
160 Hz
Stimulation
130 Hz
n 16 15
Male/female 11/5 9/6
Mean age, years 65.4 ± 4.8 68.8 ± 4.7
Disease duration, years 15.5 ± 2.4 14.46 ± 2.9
LED, mg
Pre 875.8 ± 175.9 932.6 ± 241.5
Post 351.4 ± 111.3 355.3 ± 117.6
UPDRS III MED OFF DBS Off 35.8 ± 3.2 35.9 ± 4.6
UPDRS III MED ON DBS On 20.5 ± 3.4 22.4 ± 4.0
UPDRS III MED OFF DBS On-low 35.7 ± 3.3 37.2 ± 4.2
UPDRS III MED OFF DBS On-high 35.6 ± 3.4 34.6 ± 3.2
Details are provided separately for the two groups based on the stimulation frequency.
LED = levodopa equivalent dosage; MED OFF = without medication; UPDRS =
Unified Parkinson’s Disease Rating Scale.
DBS-gamma cross-frequency coupling in PD BRAIN 2020: Page 3 of 15 | 3
D
ow
nloaded from
 https://academ
ic.oup.com
/brain/advance-article/doi/10.1093/brain/aw
aa297/5956360 by E-Library Insel user on 09 N
ovem
ber 2020
components and their linear interaction are represented as a
cross-spectral density (CSD) matrix. To visualize power at a
given frequency range, we used a linear transformation based
on a constrained optimization problem, which acts as a spatial
filter (Van Veen et al., 1997). The spatial filter assigned a specif-
ic value of power to each voxel. For a given source the beam-
former weights for a location of interest are determined by the
data covariance matrix and the LFM. Voxel size was 2 mm,
resulting in 6676 voxels covering the entire brain.
Network definition and VTA
analysis
To identify distributed regions that are affected by DBS we used
a coherent source beamforming algorithm as described in previ-
ous work (Muthuraman et al., 2018b). In short, this method
uses a reference signal to identify other sources displaying
increased coherence in an iterative manner. This reference signal
was individually extracted from a seed region within the STN
that is targeted by DBS as estimated by the VTA by stimulation.
This was done based on the clinically optimal DBS settings
using Lead-DBS [a MATLAB based toolbox for reconstructing
the implanted electrodes and simulating the stimulations (https://
www.lead-dbs.org/)]. The details of electrode localization and
VTA reconstruction have been previously described in detail
(Horn and Kühn, 2015; Horn et al., 2019). In brief, preprocess-
ing was performed using SPM12 (http://www.fil.ion.ucl.ac.uk/
spm/software/spm12) where postoperative images were linearly
co-registered to preoperative MRI and were manually controlled
for each patient and refined if needed. Obtained images were
then normalized into ICBM 2009b NLIN asymmetric space
based on the preoperative MRI and finally DBS electrode con-
tacts were localized within MNI space using Lead-DBS soft-
ware. To construct a model for volume conduction of the DBS
electrode from the active contact, a tetrahedral volume mesh
was generated based on the surface meshes of DBS electrodes
and subcortical nuclei using the Iso2Mesh toolbox (http://iso2
mesh.sourceforge.net/) as included within Lead-DBS. All param-
eters used for the reconstruction were as previously published in
Horn et al. (2019) and the voltage applied to the active elec-
trode contacts was introduced as a boundary condition (Åström
et al., 2009).
Individual masks were created by taking the pooled time ser-
ies from the individual VTA voxels as a reference signal. For the
beta (14–30 Hz) and gamma bands (31–100 Hz), a within-sub-
ject surrogate analysis was used to define the significance level
to identify activated voxels in other regions. Their activity was
then extracted from the source space. In a further analysis, all
the original source signals for each region with several activated
voxels were combined by estimating the second order spectra
and employing a weighting scheme depending on the analysed
frequency range to form a pooled source signal estimate for
each region as previously described (Rosenberg et al., 1989;
Amjad et al., 1997; Muthuraman et al., 2014). This network
was found iteratively starting from the strongest coherent source
to the weakest source. We found the sources in three cortical
regions [M1, premotor cortex (PMC), supplementary motor
area (SMA)] and two subcortical regions (STN, CER) for each
patient separately. Additionally, the posterior parietal cortex
(PPC) was used as a control region for all our analyses; the
MNI coordinates [–41, –67, 40] were taken from our previous
work on parkinsonian patients (Muthuraman et al., 2018b).
The regions’ individual subject MNI coordinates were then also
used for the On-clinical condition and the other three conditions
(Off, On-low and On-high) as reference.
Spectral analysis and
cross-frequency coupling
We separately analysed the power over five different frequency
bands, namely delta (1–3 Hz), theta (4–7 Hz), alpha (8–13 Hz),
beta (14–30 Hz) and gamma (31–100 Hz) in all six regions.
The absolute power was analysed from both ipsilateral and
contralateral hemisphere and pooled together for all four condi-
tions separately.
The cross-frequency inter-regional coupling measure of
power-power indicates how amplitude modulations in one fre-
quency in one region depend on amplitude modulations in an-
other frequency and region. In contrast to coherence measures,
the advantage of this method is that couplings can be detected
between different frequencies and even within the same region.
The estimation is done by comparing the envelopes of the sig-
nals at the given frequencies from the two regions. We estimated
the relationship between the amplitude of the higher frequency
signals (including the stimulation frequency) and the low fre-
quency signals (i.e. 1–100 Hz) by correlation. The CFC was esti-
mated with a window length of 5 s with a 50% overlap. The
complete analysis pipeline is shown in Fig. 1.
Statistical analyses
Differences in pre- and post-surgery medication were evaluated
by paired t-tests. To investigate the effect of the four stimulation
conditions on motor impairment, a one-way repeated measures
ANOVA with the within subject factor ‘stimulation condition’
(Off, On-clinical, On-low, On-high) was performed with
Unified Parkinson’s Disease Rating Scale – Part 3 (UPDRS III)
scores as dependent variable. Similar ANOVA’s were performed
for the source power of different frequency bands within the
identified regions to investigate the effect of the four stimulation
conditions on oscillatory activity within the network. Post hoc
tests for all ANOVA’s were Bonferroni corrected.
To examine whether the amount of gamma power modula-
tion is related to the amount of beta power modulation, we per-
formed Pearson correlation analyses between beta and gamma
power for the Off and On-clinical conditions and the difference
between On-clinical and Off (On-clinical  Off) of beta (dBeta)
and gamma power (dGamma).
The significance of power-to-power CFC was determined by
surrogate analyses based on the bootstrapping method
(Kaminski et al., 2001). Time series were shuffled 1000 times
and frequency-frequency clusters showing enhanced CFC in the
original time series compared to random shuffling were identi-
fied. Additionally, one-way repeated measures ANOVA with
the within subject factor ‘epoch’ of 1 min duration was per-
formed separately for the three conditions (On-clinical, On-low,
On-high) to investigate the temporal dynamics of CFC (power-
to-power) over M1. Pearson correlation was then performed to
investigate the association between CFC and the UPDRS III
scores in the On-clinical condition.
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Data availability
The data that support the findings of this study are available
from the corresponding author, upon reasonable request.
Results
Motor improvement by clinically
effective DBS
To confirm that only effective DBS alleviates motor impair-
ment, UPDRS III scores were compared for all four condi-
tions. Mean scores were 35.90±3.90 (Off), 21.48± 3.80
(On-clinical), 36.48± 3.98 (On-low), and 35.12± 3.33 (On-
high). One-way repeated measures ANOVA showed a statis-
tically significant effect of stimulation condition on UPDRS
III scores [F(3,120) = 116.30, P5 0.0001, gp2 = 0.25]. Post
hoc analysis revealed that only clinically effective stimulation
(On-clinical) significantly (P5 0.0001) reduced UPDRS III
scores. The L-DOPA equivalent dosage was significantly
decreased 6 months after the DBS procedure
(353.32± 112.56 mg, post-DBS) in comparison to pre-DBS
(903.35± 208.68 mg, pre-DBS) (t = 12.12, df = 30,
P50.0001).
VTA results
We did not find a significant difference (t = 0.86;
P = 0.3276) between the volumes of the VTA in the high
(160 Hz) and low frequency (130 Hz) groups. VTA-STN
overlap was not significantly different between the low and
high frequency group based on the Euclidean distance from
the centre of VTA MNI coordinates (t = 0.94, P = 0.2435),
demonstrating that DBS stimulates similar tissue in both
groups. The individual electrodes and clinical contact based
on the optimal clinical frequency are shown in Fig. 2A and
B, respectively. The VTA for all the subjects are shown in
Fig. 2C. No significant correlation was found between the
volumes of VTA and age, sex, or disease duration.
Coherent cortical and subcortical
sources
Using the individual VTA pooled time series as the reference,
we identified coherent sources in the regions of M1, PMC,
SMA, STN and CER. All of the identified sources were stat-
istically significant for the beta band (M1: t = 12.46,
P5 0.0001; PMC: t = 9.64, P5 0.0001; SMA: t = 12.42,
P 4 0.0001; STN: t = 8.98, P5 0.0001; CER: t = 9.93,
P5 0.0001) and for the gamma band (M1: t = 11.23,
P5 0.0001; PMC: t = 10.25, P5 0.0001; SMA: t = 11.12,
P 4 0.0001; STN: t = 9.24, P5 0.0001; CER: t = 8.42,
P5 0.0001). These regions were then examined in the fur-
ther analyses. The PPC was added as a control region.
Effective DBS reduces beta power
and increases gamma power
To identify the effect of DBS on resting state oscillatory ac-
tivity, one-way repeated measures ANOVAs were performed
Figure 1 Schematic of the analysis pipeline. (A) In a first step the VTA was calculated using lead-DBS (see also Fig. 2). (B) Utilizing the
reconstructed source time series of voxels identified by VTA analysis as a reference for the clinical stimulation condition we identified six coher-
ent sources that were used for further analyses [STN, CER, M1, premotor cortex (PMC), and supplementary motor area (SMA)]. Additionally,
the PPC was included as a control region. PD = Parkinson’s disease.
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for five different frequency bands (delta, theta, alpha, beta,
and gamma) in each of the identified regions separately to
compare source power for all four stimulation conditions
(Off, On-clinical, On-low, On-high). The results for the beta
and gamma bands are presented in Fig. 3.
There were statistically significant main effects of stimula-
tion on spectral power in the beta and gamma bands in M1
[F(3,120) = 279.53, P5 0.0001, gp2 = 0.25; F(3,120) =
81.14, P5 0.0001, gp2 = 0.25], PMC [F(3,120) = 90.94,
P5 0.0001, gp2 = 0.25; F(3,120) = 17.96, P5 0.0001,
gp2 = 0.25], SMA [F(3,120) = 90.94, P5 0.0001,
gp2 = 0.25; F(3,120) = 17.96, P5 0.0001, gp2 = 0.25],
STN [F(3,120) = 79.23, P50.0001, gp2 = 0.25; F(3,120) =
255.16, P50.0001, gp2 = 0.25], and CER [F(3,120) =
156.76, P50.0001, gp2 = 0.25; F(3,120) = 22.55,
P5 0.0001, gp2 = 0.25]. Post hoc analyses (Bonferroni
procedure, all P5 0.05) revealed that only clinical stimu-
lation (On-clinical) significantly reduced beta power and
increased gamma power. Interestingly, however, beta
power was also reduced for On-low and On-high in the
STN. Spectral power in the delta, theta, and alpha bands
was not significantly affected by any condition in any re-
gion. Additionally, there was no statistically significant ef-
fect of stimulation on spectral power in any of the bands
in the PPC [delta: F(3,120) = 1.52, P4 0.05; theta:
F(3,120) = 1.91, P4 0.05; alpha: F(3,120) = 0.24,
P4 0.05; beta: F(3,120) = 0.60, P4 0.05; gamma:
F(3,120) = 0.61, P4 0.05]. The results of these tests are
summarized in Supplementary Table 1. To summarize,
ANOVAs revealed that only the clinically effective stimu-
lation could reduce beta power and increase gamma power
in M1, PFC, SMA, and CER, but not in the PPC. The
STN was the only region that showed reduced beta power
in all three stimulation conditions, while gamma power
was again exclusively increased for the On-clinical
condition.
In the On-clinical condition, there was a significant nega-
tive linear correlation between beta- and gamma power for
all regions except the PPC (M1: r = 0.5616, P = 0.001;
PMC: r = 0.5147, P = 0.0045; SMA: r = 0.5078,
P = 0.0064; STN: r = 0.5279, P = 0.0023; CER: r =
0.4984, P = 0.0048, PPC: r = 0.1472, P = 0.724). Similar
correlations were found between dBeta and dGamma (M1:
r = 0.4470, P = 0.017; PMC: r = 0.4754, P = 0.0057;
SMA: r = 0.4587, P = 0.0078; STN: r = 0.4189,
P = 0.0043; CER: r = 0.4374, P = 0.024, PPC: 0.1026,
P = 0.845). When the stimulation was switched off there
was no significant correlation between beta and gamma
band power. Figure 4 shows correlations for M1 and STN
for both absolute power in the On-clinical condition and the
difference between the Off and the On-clinical conditions.
All P-values are Bonferroni-corrected.
Narrowband gamma activity is
coupled to VTA effects at
stimulation frequency
To investigate whether any of the DBS-related changes in os-
cillatory activities were directly coupled with stimulation
driven changes in the VTA region, we calculated the power-
to-power CFC between frequencies from 1 Hz to 100 Hz in
the regions identified above and the power between frequen-
cies from 1 Hz to 200 Hz of the signal derived from the VTA
(Fig. 5). In all regions that exhibited beta and gamma modifi-
cations, statistically significant clusters were observed between
a narrow gamma band with frequencies between 60 Hz and
80 Hz and the power at the stimulation frequency in the
VTA (Supplementary Table 2). We did not find any signifi-
cant clusters for the On-low (110 and 140 Hz) and On-high
(150 and 180 Hz) conditions, as shown in Supplementary
Figs 1–4. We found significant temporal change in the CFC
Figure 2 Electrode location and VTA. (A) DBS electrode reconstruction for all subjects using lead-DBS. Red and white colours represent
electrodes of patients stimulated with 130 Hz and 160 Hz, respectively. Subcortical structures are based on DISTAL atlas [orange: STN, green: in-
ternal globus pallidus (GPi), blue: external globus pallidus (GPe), and red: red nucleus] laid over a 7 T MRI ex vivo 100-lm thick human brain back-
ground template. Electrode contacts used for stimulation are shown in green (130 Hz) and magenta (160 Hz) and (B) VTA is shown in cyan (130
Hz) and magenta (160 Hz). (C) All electrodes locate to the sensorimotor region of the STN and VTA simulation shows that DBS primarily acti-
vates tissue in this area.
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(power-to-power) in M1 for the factor ‘epoch’ [F(54,2987.5)
= 6.74, P50.0001, gp2 = 0.108] only for the clinically ef-
fective frequency (130 and 160 Hz) (P5 0.0001) as shown
in Fig. 6A. Epoch 1 was significantly different to all the later
epochs (P5 0.0001). Epochs were not significantly different
for the On-low and On-high conditions (P4 0.05) as shown
in Fig. 6B and C. This demonstrates that the observed CFC
under the On-clinical condition needs 1 min to establish.
Importantly, such delay illustrates that the CFC does not re-
late to a stimulation artefact, since this would be established
with the onset of stimulation. Similar dynamics have also
been noted with another stimulation-related phenomenon, the
event-related resonance activity recorded at the stimulation
site in the STN. Here the frequency and amplitude of the
event-related resonance activity also takes 1 min to reach
steady state (Wiest et al., 2020). Furthermore, there was a
significant negative correlation of the gamma CFC in M1
with the UPDRS III in the On-clinical condition (r =
0.5266; P = 0.0023) as shown in Fig. 7.
Discussion
This study shows the power-to-power CFC of narrow band
gamma oscillatory activity within multiple regions of the
cortico-basal ganglia network to power at the frequency of
clinically effective DBS recorded in the VTA during rest. We
further demonstrate a negative correlation between beta and
gamma band power, and between the extent of cross fre-
quency coupling of narrow-band gamma with effective
stimulation frequency and clinical impairment, highlighting
the clinical relevance of DBS induced power-to-power-
Figure 3 Stimulation induced beta- and gamma-band power changes. One-way repeated measures ANOVAs revealed that clinical
stimulation significantly reduced beta-band and concurrently increased gamma-band power in M1, PMC, SMA, STN, CER, but not in PPC (Post
hoc test with Bonferroni procedure, all P5 0.05). Stimulating with higher or lower frequencies (in comparison to clinical frequencies) exclusively
reduced beta power in the STN.
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coupling. These findings suggest that entrainment of FTG
oscillations might promote dynamic neural processing, facili-
tating improvements of motor function in patients with
Parkinson’s disease.
DBS alleviates motor symptoms
and modulates narrow band gamma
activity
We observed a power-to-power CFC between narrowband
gamma oscillations in regions far from the stimulation target
and stimulation frequency activities in the VTA. This was
only true for stimulation at clinically effective DBS, was not
seen in the control posterior parietal region and was delayed
in onset, taking 1 min to establish itself. These features col-
lectively make it unlikely that the coupling was related to
local or volume conducted stimulation artefacts. Moreover,
the narrow band gamma power-to-power CFC itself corre-
lated negatively with motor impairment. Frequencies 430
Hz may relate to several independent processes and it is im-
portant to distinguish between broadband (30–200 Hz) and
FTG activity within a narrow band between 60–90 Hz,
thought to be responsible for arousal, attention, or vigour-
related functions (Litvak et al., 2012; Jenkinson and Kuhn,
2013). Fischer et al. (2017) demonstrated that successful
stops in a modified stop-signal task were preceded by nar-
rowband gamma activities before the patients knew they
had to stop, suggesting that FTG relates to facilitation of dy-
namic local processing rather than being uniformly proki-
netic. In this sense the FTG could be viewed as the opposite
of beta activity, which promotes the status quo (Gilbertson
et al., 2005; Engel and Fries, 2010), and it is interesting to
note the reciprocal relationship between these activities in
several key motoric regions in this study. Interestingly, stim-
ulating the STN with individually detected movement and
medication-dependent gamma peak frequencies within the
range of FTG frequencies produced similar clinical benefits
as stimulating with frequencies 4100 Hz (Tsang et al.,
2012). In addition, FTG may spontaneously involve har-
monic components that lie in the range of clinically effective
DBS frequencies, in the absence of DBS (see Fig. 2 in Brown
et al., 2001).
The observed power-to-power CFC between narrow band
gamma oscillations and the stimulation frequency VTA
effects in our study suggest that DBS with clinically effective
frequencies may trigger intrinsic FTG oscillations via an en-
trainment mechanism (Buzsaki and Wang, 2012; Li et al.,
2012; Agnesi et al., 2015; Swann et al., 2016), potentially
modifying neuronal communication in a temporally coordi-
nated manner, as proposed by Fries (2015) and thereby alle-
viating motor symptoms in Parkinson’s disease. Swann et al.
Figure 4 Association between beta and gamma power. Correlation analysis demonstrated a significant negative correlation of beta and
gamma power during the clinically effective stimulation condition (On-clinical) for M1 and STN. In addition, the difference between the On-clinic-
al and Off condition of beta and gamma power was significantly negatively correlated. The coloured regions denote the 95% confidence intervals
for the correlation. dBeta and dGamma refer to (On-clinical  Off) power estimates. The r2 and P-values are included separately for each
subplot.
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(2016) have previously demonstrated that the florid FTG
recorded at the cortical level ON medication may be
entrained by high frequency stimulation of the STN when
patients experience dyskinesia. This entrainment was mani-
fest as a shift in the frequency of the FTG peak to that of
the subharmonic (65 Hz) of the stimulation frequency (130
Hz). In contrast, CFC did not occur at precisely subharmon-
ic frequencies in our data, instead generally occurring at a
frequency that fell between the subharmonics of the two
DBS frequencies used. However, we applied stimulation
when patients were OFF levodopa, when endogenous
gamma oscillations are known to be greatly attenuated and
less well tuned (Jenkinson and Kuhn, 2013). These charac-
teristics suggest that gamma oscillations in the OFF medica-
tion state may be over-damped and therefore less susceptible
to frequency shifting when forced by external stimulation in
the form of DBS. The present findings raise the possibility
that OFF medication DBS is also able to entrain FTG, and
that these effects may be mediated by changes in the VTA/
STN region driven by clinically effective stimulation. One
candidate phenomenon in the STN is the event-related res-
onance potential (ERNA), which is harmonically related to
the stimulation frequency and takes 1 min to develop
(Sinclair et al., 2018, 2019).
Figure 5 Inter-regional CFC between the VTA reference signal and the regions of interest. CFC indices revealed clusters of nar-
rowband gamma power coupled to the stimulation frequency (A) 130 Hz and (B) 160 Hz, respectively. The black line in the colour bars indicates
the significance threshold based on surrogate analyses. See Supplementary Table 2 for ANOVA results and exact P-values.
DBS-gamma cross-frequency coupling in PD BRAIN 2020: Page 9 of 15 | 9
D
ow
nloaded from
 https://academ
ic.oup.com
/brain/advance-article/doi/10.1093/brain/aw
aa297/5956360 by E-Library Insel user on 09 N
ovem
ber 2020
Figure 6 Dynamics of CFC in M1. The temporal variation of CFC (power-to-power) in M1 for the entire 10 min divided into 10 epochs of
60 s. Stimulation was switched on at time point 0. The CFC is only significantly increased during On-clinical stimulation and takes 1 min to es-
tablish (A). This demonstrates that increased CFC does not relate to a stimulation artefact. If this was the case, increased CFC would be visible
in non-clinical stimulation and would develop from the onset of the stimulation. (A) On-clinical 130 Hz (orange) and 160 Hz (blue); (B) On-low
110 (orange) and 140 Hz (blue);and (C) On-high 150 Hz (orange) and 180 Hz (blue). Statistical analyses between the epochs are shown with red
lines: epoch 1 is significantly different to epochs 2 to 10, as shown by the black lines, but only for the On-clinical frequencies 130 Hz and 160 Hz
(P5 0.0001). The bold line indicates the mean and the shaded region indicates the standard deviation over all subjects. Note the y-axis in A dif-
fers from that in B and C.
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The fact that the observed power-to-power CFC was evi-
dent both in the absence of a specific task or dyskinesia and
correlated negatively with motor impairment suggests that
entrainment of such activities might promote dynamic proc-
essing, in line with the proposed function of FTG oscillations
(Litvak et al., 2012). The absence of power-to-power CFC
between beta band activity and the stimulation frequency,
on the other hand, indicates that beta power is not linearly
related to any direct effects of conventional DBS.
DBS modulates cortical and
subcortical beta and gamma
activities
Clinically effective DBS simultaneously reduced beta band
power and amplified gamma band power in all the regions
that were identified by coherent source beamforming of the
VTA time series. Interestingly, although beta power in the
STN was also reduced by On-low and On-high stimulation,
this was not the case in any other region, suggesting that
motor symptom alleviation cannot be achieved by exclusive-
ly reducing STN beta power but critically depends on net-
work-wide effects. Beta-band oscillations are likely related to
maintaining a current sensorimotor or cognitive state (Engel
and Fries, 2010) and exaggerated beta oscillations in
Parkinson’s disease patients might limit the information cod-
ing capacity, leading to inflexible processing (Brittain and
Brown, 2014; Tinkhauser et al., 2018). Finding attenuated
beta power within the STN is in line with recent observa-
tions that DBS alleviates excessive local synchronization in
this frequency band (Kühn et al., 2008; Oswal et al., 2016;
Tinkhauser et al., 2017). However, a stimulation-dependent
reduction of this rhythm within cortical regions is more con-
troversial. While some studies show little or no modifica-
tions of cortical beta power (de Hemptinne et al., 2015;
Oswal et al., 2016), others show beta modulations
(Whitmer et al., 2012; Abbasi et al., 2018). Whitmer et al.
(2012) found that DBS attenuated cortical signals in the beta
band in close vicinity to the putative origin of the SMA/M1
hyperdirect pathway, whereas activity of less specific regions
of the motor cortex remained unaffected. Such spatial speci-
ficity supports the hypothesis that cortical activity might be
modified by DBS antidromically. Importantly, extensive spa-
tial smoothing in the forward solution could impede the de-
tection of focal power changes. In comparison to Oswal
et al. (2016), who used a voxel size of 5 mm for the forward
solution and did not show a significant beta-decrease, a
voxel size of 2 mm used in our study seems to increase the
ability to detect local beta power decreases in the presence
of spatial selectivity. In a more recent MEG study, Abbasi
et al. (2018) used the same source reconstruction method as
we did on rest recordings to demonstrate that DBS signifi-
cantly suppressed alpha/low beta (8–22 Hz) oscillations over
M1, SMA, and PMC.
We further identified attenuated beta activation within the
CER. In one of our recent studies, we demonstrated the
pathological involvement of the CER in parkinsonian trem-
orgenesis (Muthuraman et al., 2012, 2018b) and revealed
bidirectional interactions between the CER and M1/SMA
during voluntary movements (Tamas et al., 2018). In add-
ition, evidence that di-synaptic pathways project from the
STN to the CER via the pontine nuclei has been reported in
primates (Bostan et al., 2010), providing a possible anatom-
ical link between these regions that could serve as an inter-
face for the observed power modulations in the CER.
One possible mechanism for DBS to suppress beta oscilla-
tions not only locally within the STN but also in the cortex
is the antidromic activation of deep layers within the cortex,
which might supress cortical beta power (Li et al., 2007;
Whitmer et al., 2012). This is supported by a study in rats
showing antidromic recruitment of M1 layer V neurons
with optical stimulation in STN (Gradinaru et al., 2009). An
alternative explanation is related to the disruption of patho-
logically increased information flow passing through the
STN. Untreated, excessive hyperdirect cortico-STN beta-ac-
tivity might re-innervate the cortex via the basal ganglia out-
put nuclei. DBS could increase afferent GABAergic input
from the external part of the globus pallidus (GPe) to the
STN (Chiken and Nambu, 2016). Such inhibitory input
could damp or filter cortico-STN beta activities and prevent
them from being conveyed through the STN (Brittain and
Brown, 2014; Chiken and Nambu, 2016).
In addition to the DBS-induced beta power reduction, we
found a concurrent increase of gamma power. Increased cor-
tical gamma synchronization has previously been related to
DBS (McCracken and Kiss, 2014; Cao et al., 2017) and
dopaminergic treatment (Androulidakis et al., 2007; Litvak
et al., 2012). Furthermore, we found a negative linear correl-
ation between the power in the two bands during clinically
effective stimulation which was not present when stimula-
tion was switched off. Therefore, patients with low beta
power concurrently exhibit high gamma power when stimu-
lated. Furthermore, patients that showed greater reductions
in beta power between off and On-clinical conditions also
exhibited larger increases in gamma, as demonstrated by the
Figure 7 Association between gamma CFC and UPDRS
III. Correlation analysis demonstrated a negative correlation of
gamma CFC and UPDRS III On-clinical scores during clinically ef-
fective stimulation (r = 0.5266; P = 0.0023).
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negative correlation between dBeta and dGamma. This sug-
gests that, while gamma and beta oscillations may act inde-
pendently in the absence of stimulation, DBS might elicit a
negative relationship between the two bands, thereby rein-
stating a balance between activities promoting dynamic
processing and activities promoting the status quo.
A possible explanation for the observed gamma power in-
crease in our study is that DBS-induced attenuation of beta
activity allows gamma activity to re-emerge in the subcor-
tico-cortical network. Alternatively, the potential entrain-
ment of FTG activity during clinically effective DBS might
suppress beta activity. Either way, normalizing the balance
between beta and gamma activities could improve flexible
on-demand information processing during motor
performance.
Significance of DBS effects on the
subcortico-cortical network
To our knowledge, this is the first study demonstrating that
DBS, when performed with the clinically effective frequency,
concurrently affects oscillatory activity in PMC and CER
alongside STN, M1, and SMA. We revealed modulations in
the beta and gamma band in all of these regions. Therefore,
we postulate that these network-wide DBS effects might
counteract network-wide pathological phenomena to allevi-
ate motor impairment. Particularly the gamma-band modu-
lations could be caused by an entrainment mechanism, as
suggested by high CFC with stimulation frequency power.
Stimulation frequencies other than the optimal frequency
might lack the ability to trigger such resonance. On the other
hand, the absence of power-to-power CFC between beta
and stimulation frequency indicates that beta power is not
linearly related to any direct effects of conventional DBS.
The exact mechanisms and pathways by which STN-DBS
affects the subcortico-cortical network cannot be ascertained
from the current work and merit further investigation. It
should be noted that we cannot infer any directionality or
relative circuit conduction delays from our analysis, which
prevents us from separating the relative contributions of
antidromic activation of the cortex via the hyperdirect path-
way and orthodromic activation via the pallido-thalamo-cor-
tical feedback loop.
Source analysis and VTA modelling
Applying coherent source beamforming in conjunction with
VTA modelling to resting state recordings, we illustrate
DBS-dependent spectral alterations of beta and gamma oscil-
lations over a wide network of regions that are connected to
the STN. We have previously demonstrated that distinct net-
works involved during voluntary or involuntary rhythmic
movements can be revealed by applying coherence analysis
on the source level with the aid of peripheral muscular elec-
tromyography (Anwar et al., 2016; Muthuraman et al.,
2018b; Tamas et al., 2018). Here we demonstrate that the
source activity within modelled VTA is suitable as a
reference to identify regions that exhibit DBS-dependent os-
cillatory modifications.
Clinical relevance
Altogether our findings provide further evidence that effect-
ive DBS modifies oscillatory activity within a distinct net-
work of regions connected to the stimulation site. Most of
the studies focusing on oscillatory activity within subcortical
regions of Parkinson’s disease patients were based on LFP
recordings from externalized electrodes, limiting the oppor-
tunities to collect information about the long-term and dis-
tributed effects of DBS (Neumann et al., 2019).
Additionally, in the limited time interval between surgery
and LFP recording, potential stun effects cannot be ruled out
(Chen et al., 2006; Mann et al., 2009). In previous work we
demonstrated that HD-EEG recordings can be successfully
utilized to obtain signals from cortical as well as subcortical
regions (Muthuraman et al., 2012, 2018b; Anwar et al.,
2016; Tamas et al., 2018). Here we extend these findings by
revealing cortical and subcortical DBS-induced oscillatory
modifications during rest recordings. Therefore, HD-EEG
proves to be an effective non-invasive tool for studying
pathological and treatment-related electrophysiological
adaptations in patients, even months after DBS surgery.
Efforts for finding stable and reliable biomarkers for adap-
tive closed-loop stimulation are currently focused on LFP
recordings in the STN and motor cortex (Tinkhauser et al.,
2017; Swann et al., 2018). The finding that DBS effectively
modulates a variety of cortical and subcortical regions sub-
stantially increases the number of potential locations and
measures that could be exploited for controlling the stimula-
tion. In addition, in clinical practice, finding the optimal
stimulation settings can constitute a time-consuming task,
which is currently based on subjective clinical UPDRS rat-
ings (Neumann et al., 2019). Although the UPDRS is a
widely accepted and relatively reliable tool, inter-rater reli-
ability might not be optimal, especially when performed by
less experienced individuals (Siderowf et al., 2002).
Furthermore, motor improvement evaluated unblinded can
be overestimated by up to 20% in comparison to blinded
assessment (Little et al., 2013). Hence, further advances in
the development of HD-EEG are needed that include the
automation of source reconstruction and algorithms to
probe relevant DBS-induced electrophysiological modifica-
tion. This could provide additional objective markers that
assist in finding the optimal stimulation parameters.
Limitations
While we demonstrated that effective DBS improves motor
performance, the fact that DBS at a frequency that was 20
Hz lower or higher had no effect on the UPDRS III scores is
surprising. Nevertheless, a systematic varying of stimulation
frequency in small steps has shown that only a limited num-
ber of frequencies robustly improve movement amplitude in
a tapping task, and that even small frequency deviations can
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drastically reduce efficacy (Huang et al., 2014). Similarly, Di
Giulio et al. (2019) showed peaked DBS frequency tuning
curves in gait performance.
In conjunction with the fact that CFC was not signifi-
cantly increased by non-clinical stimulation, the lack of
clinical efficacy when changing stimulation frequency by
as little as 20 Hz in our study could be related to long
term effects of chronic stimulation. All participants in our
study were chronically stimulated for 6–12 months.
Figure 6B indicates that DBS with ineffective frequencies
may slightly increase CFC after 1 min, although this is
not significant. This suggests that there is a very small
physiological effect of inefficient stimulation, which
might not be sufficient to influence the clinical state of
the patients. At this point we can only speculate that with
prolonged DBS, functional adaptations within the net-
work might induce a preferential resonance or tuning to-
wards the applied stimulation frequency, explaining the
observation that only the clinically optimized chronic
DBS frequency increased CFC and improved motor per-
formance. During the initial programming shortly after
DBS surgery, such tuning might not be present, leading to
clinically positive responses over a range of frequencies.
Further studies are needed to investigate whether tuning
is modulated by chronic stimulation. Such studies should
include a systematic testing of smaller frequency intervals
as well as serial testing of stimulation frequencies that
begins soon after surgery.
Conclusion
This study is the first to demonstrate concurrent oscilla-
tory modifications introduced by STN-DBS over a
distributed cortico-subcortical network with the help of
HD-EEG, showing that STN-DBS modifies activities in
multiple connected regions. Such network-wide impact
might ease network-wide pathological activities.
Specifically, the power-to-power CFC between FTG and
VTA power at the stimulation frequency, which correlates
with motor scores, provides further impetus to study the
role of gamma oscillations in normal and abnormal motor
control. Future studies, including effective connectivity
measures, could substantially aid in disentangling the pos-
sible mechanisms that cause the observations made here.
Biomarkers derived from HD-EEG have the potential to
provide an objective and reliable tool to support clinicians
in finding optimal stimulation parameters.
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